Sotrovimab
RG1121602
Phase 1 mab terminated
Quick answer
Sotrovimab for COVID-19 Infection is a Phase 1 program (mab) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- COVID-19 Infection
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated